Novonix Limited
NVNXF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | -0.03 | -0.04 | 0.10 |
| FCF Yield | -37.75% | -16.68% | -9.72% | -2.29% |
| EV / EBITDA | -12.54 | -6.20 | -9.72 | -15.62 |
| Quality | ||||
| ROIC | -12.78% | -10.13% | -11.86% | -8.09% |
| Gross Margin | -521.40% | -361.90% | 63.31% | -207.02% |
| Cash Conversion Ratio | – | 0.39 | 0.77 | 0.34 |
| Growth | ||||
| Revenue 3-Year CAGR | 10.78% | 21.66% | 28.08% | 28.55% |
| Free Cash Flow Growth | -69.82% | -70.75% | -284.46% | 75.93% |
| Safety | ||||
| Net Debt / EBITDA | -2.77 | -0.71 | -0.99 | 0.71 |
| Interest Coverage | -14.47 | -13.56 | -14.47 | -9.53 |
| Efficiency | ||||
| Inventory Turnover | 10.32 | 9.73 | 0.49 | 6.62 |
| Cash Conversion Cycle | 499.27 | 254.50 | -377.33 | 78.83 |